Skip to content

2-duct ligation versus botulinum toxin for severe drooling in children with cerebral palsy

2-duct ligation versus botulinum toxin for severe drooling in children with cerebral palsy - 2-duct ligation versus botulinum toxin for severe drooling

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37173
Enrollment
60
Registered
2011-07-12
Start date
2012-04-02
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

drooling sialorrhea

Interventions

Participants in the study undergo either injection with botulinum toxin or 2-duct ligation. Both procedures are performed in daycare surgery. A) 2-duct ligation The patient is put under general ane
Allergan, Nieuwegein, Netherlands), reconstituted with 0.9% sodium chloride solution, is injected bilaterally in the submandibular glands using a 25-G needle and a 1-mL syringe. On injection, each

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age 6 years or above - Cerebral palsy or other non-progressive neurological disease - Severe drooling (Drooling Frequency >=3; Drooling Severity >=2) - Conservative treatment has not led to adequate reduction of droolng - Informed consent - Cognitive ability of parents is adequate to participate in the study, as judged by the researchers. - Participants are motived to return for follow up after 2, 8 and 32 weeks.

Exclusion criteria

Exclusion criteria: - Concurrent participation in other medical study - Previous surgery or anatomical abnormalities that prohibit either application of botulinum toxin or surgery - Concurrent other treatment for drooling - Use of benzodiazepines - Allergy to botulinum toxin or other contraindication for botulinumtoxin or surgery.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study is the extent of drooling. This is mainly assessed using the drooling quotient and a VAS-score. Both methods have been used significantly. The drooling quotient is a validated tool to semi-objectively quantify the extent of drooling. During two ten-minute sessions, the absence or presence of new saliva on the lip is recorded every fifteen seconds. The first session is performed while resting, the second while a child is distracted. The drooling quotient is obtained by dividing the number of observed drooling episodes by 0.4. The resulting quotient reflects the relative time a person drools. The VAS is recorded by parents or caretakes, to investigate therapy results as experienced in the home situation. Scales of exactly 10 cm without visible subdivisions are presented, on which the average degree of drooling severity during the 10 to 14 days before assessment is to be indicated. A mark at the left end represents severe drooling; a mark at the right end means no drooling.

Secondary

MeasureTime frame
Secondary outcomes are the extent of drooling, quality of life, complications, admission time and duration of the procedure.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)